Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes: The PREPARED Trial
Northwestern University
840 participants
May 6, 2022
INTERVENTIONAL
Conditions
Summary
This study is being done to investigate strategies that may improve patient's knowledge of type 2 diabetes during reproductive age and improve knowledge and engagement in self-care activities.
Eligibility
Inclusion Criteria7
- female
- age 18-44
- English or Spanish-speaking
- have a chart diagnosis of type 2 diabetes
- not currently pregnant
- not infecund, sterilized, or in a monogamous relationship with a sterilized partner
- have a private cell phone with text messaging capability.
Exclusion Criteria1
- severe, uncorrectable vision, hearing, or cognitive impairments that would preclude study consent or participation
Interventions
Patients will receive a print MedRec tool, generated via the EHR, which includes a list of medications prescribed according to the patient record. Patients are asked to review this list, to add/remove drugs to reflect actual use, to note how they are taking each medication, and to describe any concerns.
During the clinic visit, an automated, EHR alert will notify the provider that the patient is a woman of reproductive age with T2DM and should receive counseling on the importance of glycemic control, the use of contraception until glycemic control is achieved, and the benefits of folic acid.
When patients leave an encounter, they will receive a patient-friendly educational material (a.k.a. the PREPSheet) that reviews potential risks of pregnancy in the context of T2DM and highlights the importance of: 1) achieving glycemic control through diabetes self-care, 2) using effective contraception until glycemic control is achieved and pregnancy is desired, 3) discussing medication use with a provider if planning or becoming pregnant, and 4) taking folic acid daily to reduce increased risk of neural tube defects.
Within \~5 days of their index clinic visit, intervention patients will begin to receive daily, unidirectional text messages to reinforce diabetes self-care behaviors.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04976881